Jaguar Health (JAGX) Net Margin (2015 - 2026)

Jaguar Health (JAGX) reported Net Margin of 34.6% for Q1 2026, up 43802.0% year-over-year from N/an in Q1 2025, and up 95.17% quarter-over-quarter from 716.94% in Q4 2025.

Jaguar Health (JAGX) Net Margin (2015 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 12 years of Net Margin data on file, last reported at 34.6% in Q1 2026.

  • Net Margin for Q1 2026 came in at 34.6%, up 43802.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 170.5% (up 17758.0% YoY), and the FY2025 annual result was 465.42%, down 13612.0% from the prior year.
  • Net Margin advanced to 34.6% in Q1 2026 per JAGX's latest filing, from 716.94% in the prior quarter.
  • Over five years, Net Margin peaked at 34.6% in Q1 2026 and troughed at 89930.0% in Q1 2022.
  • A 5-year average of 8578.26% and a median of 392.43% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2023: Net Margin sank 8896231 bps in 2022, then soared 6281444 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 23690.62% in 2022, then surged by 98 bps to 398.7% in 2023, then advanced by 27 bps to 291.65% in 2024, then sank by 146 bps to 716.94% in 2025, then soared by 95 bps to 34.6% in 2026.
  • Business Quant data shows JAGX's Net Margin at 34.6% in Q1 2026, 716.94% in Q4 2025, and 312.94% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 34.53%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Jaguar Health 1.44 Mn -10.19 Mn 19.11 Mn -34.60%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.60%
Dec 31, 2025 -716.94%
Sep 30, 2025 -312.94%
Jun 30, 2025 -354.48%
Mar 31, 2025 -472.63%
Dec 31, 2024 -291.65%
Sep 30, 2024 -322.43%
Jun 30, 2024 -348.84%
Mar 31, 2024 -392.43%
Dec 31, 2023 -398.70%
Sep 30, 2023 -276.50%
Jun 30, 2023 -454.04%
Mar 31, 2023 -27,115.56%
Dec 31, 2022 -23,690.63%
Sep 30, 2022 -397.46%
Jun 30, 2022 -320.68%
Mar 31, 2022 -89,930.00%
Dec 31, 2021 -670.40%
Sep 30, 2021 -1,935.24%
Jun 30, 2021 -3,715.30%